Genomic duplication in Dyggve Melchior Clausen syndrome, a novel mutation mechanism in an autosomal recessive disorder.
BACKGROUND
Dyggve Melchior Clausen syndrome (DMC) is a severe autosomal recessive skeletal dysplasia associated with mental retardation. Direct sequencing of genomic DNA has identified causative mutations in the gene Dymeclin (chromosome 18q12-21), with the majority predicting the generation of a truncated protein product.


OBJECTIVE
To carry out molecular genetic studies in three DMC kindreds.


RESULTS
Two novel nonsense mutations and two complex genomic duplication events resulting in exon repetition were identified.


CONCLUSIONS
Exon dosage assessment or mRNA analysis, in addition to direct genomic DNA sequencing, should be employed in the investigation of DMC affected individuals. Genomic duplication may be the causative mutation mechanism in other autosomal recessive disorders.
Kinning
E
E
Division of Medical Genetics, Department of Genetics and Cardiovascular Science, University of Leicester, Leicester, UK.
Tufarelli
C
C
Winship
W S
WS
Aldred
M A
MA
Trembath
R C
RC
D005192:Family Health; D005260:Female; D020440:Gene Duplication; D005808:Genes, Recessive; D020022:Genetic Predisposition to Disease; D023281:Genomics; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008297:Male; D008957:Models, Genetic; D009154:Mutation; D010009:Osteochondrodysplasias / Q000235:genetics*; D010375:Pedigree; D011506:Proteins / Q000235:genetics*; D012333:RNA, Messenger / Q000378:metabolism; D013577:Syndrome
C477370:DYM protein, human; D047908:Intracellular Signaling Peptides and Proteins; D011506:Proteins; D012333:RNA, Messenger